AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Miconazole Nitrate in South Africa
7 products registered with SAHPRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| GYNO-DAKTARIN 1 200 mg | 29/18.6/0349 | Johnson & Johnson (Pty) Ltd û East London | suspended | 18 Aug 2025 |
| GYNOSPOR VAGINAL CREAM | S/18.6/85 | Pharmacare Limited û Woodmead | suspended | 29 Jul 2024 |
| DAKTARIN CREAM* | G/13.9.2/106 | Janssen Pharmaceutica (Pty) Ltd | suspended | 1 Mar 2023 |
| TIBOZOLE | 37/20.2.2/0100 | Janssen Pharmaceutica (Pty) Ltd | suspended | 7 Dec 2022 |
| GYNO-DAKTARIN 200 mg | L/18.6/368 | Janssen Pharmaceutica (Pty) Ltd | suspended | 19 Mar 2021 |
| COVAREX | 33/13.9.2/0124 | Glenmark Pharmaceuticals South Africa (Pty) Ltd | active | 1 Jan 1900 |
| DERMAZOLE | 34/13.9.2/0182 | Unimed Healthcare (Pty) Ltd | active | 1 Jan 1900 |
Miconazole Nitrate — SAHPRA Registration Details
SAHPRA (South Africa) has 7 registered products containing Miconazole Nitrate, of which 2 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Miconazole Nitrate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.